Select your location for location specific information:
The Free State of Bavaria supports cooperation projects in the field of life sciences, with a focus on biotechnology and genetic engineering, provided they can be assigned to industrial research or experimental development.
The funding is intended to enable companies in the commercial sector to carry out fundamental research and development work in the field of modern biotechnology and genetic engineering and to enable or accelerate the implementation of research and development results in modern biotechnology and genetic engineering in new products, new processes, new technologies and new knowledge-based services.
The funding covers the following topics and issues in particular:
Priority is given to research and development projects that are embedded in a growth-oriented corporate strategy.
Eligible applicants are
The research, development and innovation (R&D&I) projects must be carried out in close cooperation between several companies from the commercial sector or between such companies and research institutions. Several partners along the value chain should cooperate. Preference will be given to small and medium-sized enterprises (SMEs).
The following can be funded
The grant is provided as partial funding in the form of subsidies as part of project funding.
The aid intensity is
In the case of collaborative projects, the aid intensity is determined for each individual beneficiary; the maximum aid intensity for the collaborative project is 50 percent. In addition, up to 15 percentage points can be granted for industrial project partners if the requirements of Art. 25 (6) (b) GBER are met.
If different project activities can be assigned to both industrial research and experimental development, the funding rate will be determined on a pro rata basis.
The Free State of Bavaria promotes the research, development and application of new energy and energy-saving technologies.